RO6807952

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Diabetes Mellitus Type 2

Phase 1

A Study of RO6807952 in Patients With Diabetes Mellitus Type 2

CompletedNCT01358929

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2011-04-30End: 2011-09-30Updated: 2016-11-02

Phase 2

Study of RO6807952 in Patients With Diabetes Mellitus Type 2

TerminatedNCT01516476

Hoffmann-La RocheDiabetes Mellitus Type 2

Start: 2011-11-30End: 2012-01-31Updated: 2016-11-02